A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Completed · Phase 3

Conditions studied: Meningitis, Meningococcal

In brief

This study will evaluate the safety and immune response of the Novartis Meningococcal ACWY conjugate vaccine when administered with routine infant vaccinations to healthy infants.

Key facts

Study ID
NCT00474526
Run by
Novartis Vaccines
People needed
4545
Starts
2007-03-01
Expected to finish
2009-11-01
Last updated by the study team
2014-03-24

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.